Azenta, Inc. Stock price

Equities

AZTA

US1143401024

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
60.28 USD +1.43% Intraday chart for Azenta, Inc. +1.77% -7.46%
Sales 2024 * 704M Sales 2025 * 743M Capitalization 3.36B
Net income 2024 * -27M Net income 2025 * -17M EV / Sales 2024 * 4.78 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 4.53 x
P/E ratio 2024 *
-96.6 x
P/E ratio 2025 *
-126 x
Employees 3,500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 79.02%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.43%
1 week+2.71%
Current month-7.48%
1 month-7.42%
3 months-9.08%
6 months+25.85%
Current year-7.46%
More quotes
1 week
57.62
Extreme 57.62
61.17
1 month
57.58
Extreme 57.58
67.77
Current year
57.58
Extreme 57.58
69.16
1 year
36.01
Extreme 36.01
69.16
3 years
36.01
Extreme 36.01
124.79
5 years
21.19
Extreme 21.19
124.79
10 years
8.33
Extreme 8.33
124.79
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 10-04-04
Director of Finance/CFO 50 23-10-15
Chief Tech/Sci/R&D Officer - 17-06-30
Members of the board TitleAgeSince
Director/Board Member 63 Jan. 29
Director/Board Member 65 Jan. 29
Chief Executive Officer 65 10-04-04
More insiders
Date Price Change Volume
24-03-28 60.28 +1.43% 367,329
24-03-27 59.43 +1.78% 331,851
24-03-26 58.39 +0.99% 346,623
24-03-25 57.82 -2.51% 393,058
24-03-22 59.31 +0.14% 516,466

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Azenta, Inc. is a provider of life science sample exploration and management solutions for the life sciences market. The Company operates through two segments: Life Sciences Products, and Life Sciences Services. The Life Sciences Products segment provides automated cold storage solutions for biological and chemical compound samples. The segment’s product offerings include automated cold storage systems, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. The Life Sciences Services segment provides solutions addressing the many needs of customers in genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The segment’s service offerings include genomic services, and sample repository solutions. Its brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B Medical Systems.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
60.28 USD
Average target price
72 USD
Spread / Average Target
+19.44%
Consensus
  1. Stock
  2. Equities
  3. Stock Azenta, Inc. - Nasdaq